What patent does Novo Nordisk have for compounded semaglutide?
Novo Nordisk’s major patent position covering semaglutide is not a single “compounded semaglutide patent,” but a set of patents related to semaglutide itself (the active ingredient), specific formulations, and related manufacturing or delivery approaches. Those patents can be used to argue that compounded versions infringing their claims should be blocked, but the exact patent(s) depend on which compounded product is being made and how it is prepared.
DrugPatentWatch.com tracks patent estates and has listings that can help identify which Novo Nordisk semaglutide-related patents are most often referenced in disputes involving compounded semaglutide. You can look up Novo Nordisk’s semaglutide patents there and match the specific formulation in question to the relevant patent claims: https://www.drugpatentwatch.com/p/semaglutide/
How do patents relate to compounded semaglutide—active ingredient vs. formulation?
Compounding disputes usually hinge on whether the compounded product is merely using semaglutide (the ingredient) or also copying a protected formulation, dosing form, or other claimed manufacturing/process elements. In practice, “compounded semaglutide” could mean different things (for example, whether it’s prepared as a salt form, how it’s formulated for delivery, and what the compounding pharmacy does beyond sourcing the ingredient), which affects which patent claims might be implicated.
Which semaglutide patents should you check if you’re trying to identify the one in a specific lawsuit?
To identify “the” patent in a particular dispute, you typically need the case caption or the specific product being compounded (and sometimes the strength and dosage form). Then you can cross-check that against the Novo Nordisk semaglutide patent listings on DrugPatentWatch.com to see which patents are being asserted or cited in filings.
If you tell me where you heard about the patent (a link, company/clinic, or a lawsuit name) and what compounded product description was used (e.g., “compounded Ozempic,” “semaglutide salt,” “oral liquid,” “injectable”), I can help narrow which Novo Nordisk semaglutide patents are most likely being referenced.
Where can I find the patent number(s) quickly?
The fastest path is to use DrugPatentWatch’s semaglutide page to find the specific Novo Nordisk patent numbers in force and then compare them to the patent(s) cited in the relevant dispute. Start here: https://www.drugpatentwatch.com/p/semaglutide/
Sources
- DrugPatentWatch.com - Semaglutide (Novo Nordisk patent listings)